(801) 486-1818Inflammation Treatments
Inflammation is an integral finding in numerous medical conditions and coincides with nearly all types of injuries and insults to the body. Numerous studies have reported chronic inflammation in Alzheimer’s disease, Atherosclerosis, Autism, Cancer, Stroke, Diabetes, Traumatic Brain Injury and many other chronic health challenges. Hyperbaric oxygen therapy (HBOT) has been demonstrated to substantially attenuate inflammation throughout the body to help with traditional inflammation treatments.
HBOT drives increased levels of oxygen into the body, which travels through the plasma, subsequently reducing inflammation and pain. Studies have shown that HBOT aids in inflammation treatments by an increase in anti-inflammatory levels and provides cellular aid to heal target regions. As oxygen serves as one of the primary mechanisms to ameliorating inflammation, HBOT creates the environment where this process is stimulated and enhanced. Studies have demonstrated the benefits of HBOT for inflammation with the following:
Support Anti-Inflammatory Process at the Cellular Level with HBOT
- Decreases Acute/Chronic Inflammation
- Increases Anti-Inflammatory Cytokines
- Accelerates Fibroblast Activation
- Minimizes Pain & Discomfort
- Reduces Swelling
Prevent the Onset of Chronic Inflammatory Related Diseases with HBOT
- Attenuates Cancer Risk & Progression
- Ameliorates Diabetic Conditions Linked to Inflammation
- Reduces Risk of Atherosclerosis, Heart Attack & Stroke
Decrease Gastrointestinal Inflammation with HBOT
- Remediates Inflammatory Bowel Disease
- Improves Nutritional Absorption
- Ameliorates Ulcerative Colitis
Relieve Soft Tissue/Joint Inflammation with HBOT
- Remediates Osteoarthritis & Rheumatoid Arthritis
- Accelerates Recovery from Sports-Related & High Impact Injuries
- Ameliorates Tendinitis
Reduce Neuroinflammation with HBOT
- Ameliorates Autism Symptoms
- Reduces Risk of Alzheimer’s & Parkinson’s Disease
- Supports the Prevention & Treatment of Stroke
Study: Atherosclerosis & Inflammation Attenuated with HBOT
A study published in July, 2008 examined the effects of HBOT on atherosclerosis with Apolipoprotein E-deficient Knockout (apoEKO) mice. Two groups of mice were treated with either 5 or 10 weeks of HBOT, whereas two other groups remained untreated and used as a control group. After the introduction of low density lipoprotein, the treated group exhibited positive changes in the immune/ inflammatory response. This represents a critical component of the beneficial effects of HBOT.
This study demonstrated that HBOT significantly reduced the circulating levels of low density lipoprotein that can cause heart disease, kidney disease and stroke. Additionally, HBOT resulted in a substantial attenuation in the production of pro-inflammatory cytokines in response to an inflammatory stimulus, and showed a marked increase in the production of anti-inflammatory cytokine IL-10 (Interleukin 10) by spleen cells. The observed improvements were already noted after only 5 weeks of treatments.